European Commision approves Amgen´s KINERET® for the treatment of rheumatoid arthritis
First Interleukin-1 receptor antagonist represents new way to treat RA
13-Mar-2002 -
THOUSAND OAKS, Calif. and LUCERNE, Switzerland, March 13, 2002 - Amgen today announced that the European Commission has approved Kineret® (anakinra) for the treatment of the signs and symptoms of rheumatoid arthritis (RA) in combination with methotrexate, in patients with an inadequate response ...
Amgen
anakinra
arthritis
+6